Expression of clusterin, XIAP and survivin, and their changes by camptothecin (CPT) treatment in CPT resistant PC-3 and CPT-sensitive LNCaP cells

Aim: Clusterin and IAPs (inhibitor of apoptosis proteins), such as survivin and XIAP, are known to be related to chemo-resistance in several cancer cells. In the current study, we investigated their expression levels in human prostate cancer cell lines, LNCaP and PC-3 which are sensitive and resista...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Datum:2006
Hauptverfasser: Mizutani, K., Matsumoto, K., Hasegawa, N., Deguchi, T., Nozawa, Y.
Format: Artikel
Sprache:English
Veröffentlicht: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2006
Schriftenreihe:Experimental Oncology
Schlagworte:
Online Zugang:http://dspace.nbuv.gov.ua/handle/123456789/137572
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Zitieren:Expression of clusterin, XIAP and survivin, and their changes by camptothecin (CPT) treatment in CPT resistant PC-3 and CPT-sensitive LNCaP cells / K. Mizutani, K. Matsumoto, N. Hasegawa, T. Deguchi, Y. Nozawa // Experimental Oncology. — 2006. — Т. 28, № 3. — С. 209-215. — Бібліогр.: 26 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine
Beschreibung
Zusammenfassung:Aim: Clusterin and IAPs (inhibitor of apoptosis proteins), such as survivin and XIAP, are known to be related to chemo-resistance in several cancer cells. In the current study, we investigated their expression levels in human prostate cancer cell lines, LNCaP and PC-3 which are sensitive and resistant to camptothecin (CPT), topoisomerase I inhibitor, respectively. Methods: LNCaP and PC-3 cells were cultured in the presence of CPT, cell death was evaluated using Hoechst 33342 and propidium iodide (PI) double staining. The expression of clusterin, XIAP and survivin on mRNA and protein levels was investigated by semi-quantitative RT-PCR and Western blotting, respectively. Results: Our data showed that 24 h treatment of LNCaP cells with 0.5 and 3.0 µM CPT resulted in higher number of apoptotic cells, than that in PC-3 cells. Western blot analysis revealed that the clusterin level in PC-3 cells was 5-fold higher than that in LNCaP cells. In contrast, XIAP expression level in PC-3 cells was lower than that in LNCaP cells, and survivin levels were similar in these two cell lines. Treatment with 0.5 and 3.0 µM CPT resulted in the reduced survivin and XIAP expression in both cell lines, while clusterin expression remained unchanged in LNCaP cells, but was increased in PC-3 cells. Conclusion: The results suggest that clusterin may take a greater part in CPT-resistance than survivin and XIAP in PC-3 cells.